Propanc Biopharma, Inc. (PPCB)

Propanc Biopharma Statistics

Total Valuation

PPCB has a market cap or net worth of $6.18 million. The enterprise value is $6.27 million.

Market Cap	6.18M
Enterprise Value	6.27M

Important Dates

The next estimated earnings date is Sunday, February 15, 2026, before market open.

Earnings Date	Feb 15, 2026
Ex-Dividend Date	n/a

Share Statistics

PPCB has 13.36 million shares outstanding.

Current Share Class	13.36M
Shares Outstanding	13.36M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+6.20%
Owned by Insiders (%)	62.53%
Owned by Institutions (%)	4.57%
Float	5.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.41
P/TBV Ratio	0.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.45, with a Debt / Equity ratio of 0.05.

Current Ratio	2.45
Quick Ratio	0.17
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-78.73

Financial Efficiency

Return on equity (ROE) is -1,236.83% and return on invested capital (ROIC) is -639.56%.

Return on Equity (ROE)	-1,236.83%
Return on Assets (ROA)	-427.27%
Return on Invested Capital (ROIC)	-639.56%
Return on Capital Employed (ROCE)	-428.10%
Revenue Per Employee	n/a
Profits Per Employee	-$31.70M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -97.43% in the last 52 weeks. The beta is 3.25, so PPCB's price volatility has been higher than the market average.

Beta (5Y)	3.25
52-Week Price Change	-97.43%
50-Day Moving Average	0.80
200-Day Moving Average	3.93
Relative Strength Index (RSI)	23.07
Average Volume (20 Days)	78,303

Short Selling Information

The latest short interest is 236,669, so 1.77% of the outstanding shares have been sold short.

Short Interest	236,669
Short Previous Month	257,345
Short % of Shares Out	1.77%
Short % of Float	4.73%
Short Ratio (days to cover)	0.91

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-61.66M
Pretax Income	-63.41M
Net Income	-63.41M
EBITDA	-61.66M
EBIT	-61.66M
Earnings Per Share (EPS)	-$9.00

Balance Sheet

The company has $602,737 in cash and $695,068 in debt, with a net cash position of -$92,331 or -$0.01 per share.

Cash & Cash Equivalents	602,737
Total Debt	695,068
Net Cash	-92,331
Net Cash Per Share	-$0.01
Equity (Book Value)	14.36M
Book Value Per Share	1.12
Working Capital	5.19M

Cash Flow

In the last 12 months, operating cash flow was -$2.11 million and capital expenditures -$2,491, giving a free cash flow of -$2.11 million.

Operating Cash Flow	-2.11M
Capital Expenditures	-2,491
Free Cash Flow	-2.11M
FCF Per Share	-$0.16

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PPCB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-1,026.50%
FCF Yield	-34.18%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 29, 2025. It was a reverse split with a ratio of 1:59,880.24.

Last Split Date	Jan 29, 2025
Split Type	Reverse
Split Ratio	1:59,880.24

Scores

Altman Z-Score	n/a
Piotroski F-Score	2